These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 22918121

  • 1. Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements.
    Nishi M, Eguchi-Ishimae M, Wu Z, Gao W, Iwabuki H, Kawakami S, Tauchi H, Inukai T, Sugita K, Hamasaki Y, Ishii E, Eguchi M.
    Leukemia; 2013 Feb; 27(2):389-97. PubMed ID: 22918121
    [Abstract] [Full Text] [Related]

  • 2. Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale.
    Stumpel DJ, Schotte D, Lange-Turenhout EA, Schneider P, Seslija L, de Menezes RX, Marquez VE, Pieters R, den Boer ML, Stam RW.
    Leukemia; 2011 Mar; 25(3):429-39. PubMed ID: 21116279
    [Abstract] [Full Text] [Related]

  • 3. Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia.
    Stam RW, den Boer ML, Passier MM, Janka-Schaub GE, Sallan SE, Armstrong SA, Pieters R.
    Leukemia; 2006 Feb; 20(2):264-71. PubMed ID: 16357833
    [Abstract] [Full Text] [Related]

  • 4. Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.
    Schafer E, Irizarry R, Negi S, McIntyre E, Small D, Figueroa ME, Melnick A, Brown P.
    Blood; 2010 Jun 10; 115(23):4798-809. PubMed ID: 20215641
    [Abstract] [Full Text] [Related]

  • 5. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
    Schotte D, Lange-Turenhout EA, Stumpel DJ, Stam RW, Buijs-Gladdines JG, Meijerink JP, Pieters R, Den Boer ML.
    Haematologica; 2010 Oct 10; 95(10):1675-82. PubMed ID: 20494936
    [Abstract] [Full Text] [Related]

  • 6. The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia.
    Stumpel DJ, Schneider P, Pieters R, Stam RW.
    Eur J Cancer; 2015 Sep 10; 51(14):2008-21. PubMed ID: 26188848
    [Abstract] [Full Text] [Related]

  • 7. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression.
    Dou L, Zheng D, Li J, Li Y, Gao L, Wang L, Yu L.
    Oncogene; 2012 Jan 26; 31(4):507-17. PubMed ID: 21706045
    [Abstract] [Full Text] [Related]

  • 8. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
    Gessner A, Thomas M, Castro PG, Büchler L, Scholz A, Brümmendorf TH, Soria NM, Vormoor J, Greil J, Heidenreich O.
    Leukemia; 2010 Oct 26; 24(10):1751-9. PubMed ID: 20686504
    [Abstract] [Full Text] [Related]

  • 9. HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia.
    Wu Z, Eguchi-Ishimae M, Yagi C, Iwabuki H, Gao W, Tauchi H, Inukai T, Sugita K, Ishii E, Eguchi M.
    Br J Haematol; 2015 Dec 26; 171(5):818-29. PubMed ID: 26403224
    [Abstract] [Full Text] [Related]

  • 10. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H, Jiang X, Wang J, Li Y, Song CX, Chen P, Li S, Gurbuxani S, Arnovitz S, Wang Y, Weng H, Neilly MB, He C, Li Z, Chen J.
    Cancer Lett; 2016 Mar 28; 372(2):157-65. PubMed ID: 26791235
    [Abstract] [Full Text] [Related]

  • 11. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
    Driessen EM, van Roon EH, Spijkers-Hagelstein JA, Schneider P, de Lorenzo P, Valsecchi MG, Pieters R, Stam RW.
    Haematologica; 2013 Jun 28; 98(6):937-44. PubMed ID: 23403319
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene.
    Dou L, Li J, Zheng D, Li Y, Gao X, Xu C, Gao L, Wang L, Yu L.
    Mol Biol Rep; 2013 Dec 28; 40(12):6811-9. PubMed ID: 24057258
    [Abstract] [Full Text] [Related]

  • 13. [Biological microchip for establishing the structure of fusion transcripts involving MLL in children with acute leukemia].
    Nasedkina TV, Ikonnikova AY, Tsaur GA, Karateeva AV, Ammour YI, Avdonina MA, Karachunskii AI, Zasedatelev AS.
    Mol Biol (Mosk); 2016 Dec 28; 50(6):968-977. PubMed ID: 28064313
    [Abstract] [Full Text] [Related]

  • 14. Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Stam RW, Den Boer ML, Schneider P, de Boer J, Hagelstein J, Valsecchi MG, de Lorenzo P, Sallan SE, Brady HJ, Armstrong SA, Pieters R.
    Blood; 2010 Feb 04; 115(5):1018-25. PubMed ID: 19965632
    [Abstract] [Full Text] [Related]

  • 15. The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.
    Wang WT, Chen TQ, Zeng ZC, Pan Q, Huang W, Han C, Fang K, Sun LY, Yang QQ, Wang D, Luo XQ, Sun YM, Chen YQ.
    J Hematol Oncol; 2020 Jun 17; 13(1):78. PubMed ID: 32552847
    [Abstract] [Full Text] [Related]

  • 16. [Expression Analysis and Epigenetics of MicroRNA let-7b in Acute Lymphoblastic Leukemia].
    Xu WQ, Huang YM, Xiao HF.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec 17; 23(6):1535-41. PubMed ID: 26708866
    [Abstract] [Full Text] [Related]

  • 17. Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.
    Chijimatsu I, Imanaka Y, Tomizawa D, Eguchi M, Nishimura S, Karakawa S, Miki M, Hamamoto K, Fujita N.
    Pediatr Blood Cancer; 2017 Dec 17; 64(12):. PubMed ID: 28675638
    [Abstract] [Full Text] [Related]

  • 18. Identification of co-expressed genes associated with MLL rearrangement in pediatric acute lymphoblastic leukemia.
    Zhang H, Liu B, Cheng J, Ma H, Li Z, Xi Y.
    Biosci Rep; 2020 May 29; 40(5):. PubMed ID: 32347296
    [Abstract] [Full Text] [Related]

  • 19. MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia.
    Jiang X, Huang H, Li Z, He C, Li Y, Chen P, Gurbuxani S, Arnovitz S, Hong GM, Price C, Ren H, Kunjamma RB, Neilly MB, Salat J, Wunderlich M, Slany RK, Zhang Y, Larson RA, Le Beau MM, Mulloy JC, Rowley JD, Chen J.
    Proc Natl Acad Sci U S A; 2012 Nov 20; 109(47):19397-402. PubMed ID: 23132946
    [Abstract] [Full Text] [Related]

  • 20. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia.
    Chen L, Sun Y, Wang J, Jiang H, Muntean AG.
    Oncotarget; 2016 May 03; 7(18):25208-23. PubMed ID: 27007052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.